@chlo_mckernan's Wegovy week 2 claims, fact-checked

What does this video actually claim?

@chlo_mckernan reports losing 1 pound after two weeks on Wegovy, experiencing no side effects, and having strong appetite suppression. She mentions this weight loss "wasn't the plan" but seems pleased with how she's feeling overall.

The creator also talks about her hair improvement after months of proper care, though this appears unrelated to her Wegovy use. Her post uses hashtags mixing Wegovy with Mounjaro, which are different medications entirely.

Is 1 pound of weight loss after 2 weeks normal?

Actually, yes. The STEP 1 trial (Wilding et al., NEJM, 2021) showed most participants started with 0.25mg weekly doses and didn't see dramatic early losses. At 4 weeks, the average was around 2-3% body weight reduction.

For someone weighing 150 pounds, that's 3-4.5 pounds in the first month. Chlo's 1 pound in 2 weeks tracks perfectly with clinical trial data. The medication's effects typically increase as doses escalate over 16-20 weeks to the full 2.4mg maintenance dose.

Her comment about weight loss not being "the plan" is odd since Wegovy is specifically FDA-approved for chronic weight management, not other uses.

What about her "no side effects" claim?

She's lucky, but this won't last. The STEP trials found 74% of participants experienced gastrointestinal side effects, most commonly nausea (44%), diarrhea (30%), and vomiting (24%). These typically emerge as doses increase.

At the starting 0.25mg dose, side effects are relatively mild. The real test comes at 1.0mg and higher doses. The SUSTAIN 1 trial (Sorli et al., Diabetes Care, 2017) showed side effect rates doubled between low and high semaglutide doses.

Her strong appetite suppression matches the drug's mechanism. Semaglutide activates GLP-1 receptors in the brain's appetite control centers, which the STEP trials confirmed produces significant satiety effects.

Why is she mixing Wegovy and Mounjaro hashtags?

This is confusing and potentially misleading. Wegovy contains semaglutide, while Mounjaro contains tirzepatide. They're different medications with different mechanisms and different clinical profiles.

The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found tirzepatide produced 20.9% weight loss at the highest dose versus 14.9% for semaglutide in STEP 1. Using both hashtags makes it unclear which drug she's actually taking.

This hashtag mixing happens frequently in the "GLP-1 community" but creates confusion about which medication produces which effects.

What should you actually know about early Wegovy use?

Week 2 experiences don't predict long-term outcomes. The medication's full effects emerge over 68 weeks, according to STEP trial data. Early appetite suppression is common, but so are delayed side effects as doses increase.

Most people start noticing significant weight changes around weeks 8-12 when reaching higher doses. The 0.25mg starting dose is primarily for tolerance building, not maximum efficacy.

If you're considering Wegovy, expect a months-long journey with dose escalations every 4 weeks. The drug costs around $1,300 monthly without insurance coverage, and requires ongoing use to maintain weight loss benefits.